Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting
暂无分享，去创建一个
P. Morange | L. Bertoletti | E. de Raucourt | A. Lebreton | Anne-Céline Martin | P. Roy | A. Viallon | P. Gaussem | L. Camoin-Jau | D. Smadja | P. Billoir | A. Lillo-Le Louët | R. Chocron | N. Gendron | N. Ajzenberg | D. Lasne | D. Faille | V. Le Cam Duchez | D. Teissandier | J. Brunier | C. Ladhari | Juliette Gay | M. Tuffigo | Corentin Bonnet | Ludovic Suner | Paul Billoir